SA
Shamim Adil Michal
About Shamim Adil Michal
Data last updated:
Shamim Adil Michal is a Director at Supha Pharmachem Limited (since 2025). The company operates in Pharma. Supha Pharmachem Limited reported revenue of ₹233 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Supha Pharmachem Limited L24100MH1988PLC343805 | Director | 22 Jan 2025 | 1988 | ₹233 Cr (FY 2025) | Active |
Board colleagues of Shamim Adil Michal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Adarsh Deepak Munjal | 07304004 | Supha Pharmachem Limited | Director |
| Ashish Dinanath Parkar | Supha Pharmachem Limited | Cfo | |
| Bikram Kumar Mund | 06919513 | Supha Pharmachem Limited | Director |
| Rambhajan Vishwakarma | 11360922 | Supha Pharmachem Limited | Director |
| Vignesh Laxman Gawde | 11360925 | Supha Pharmachem Limited | Whole-Time Director |
| Vijay Pal Singh Gulya | 01433784 | Supha Pharmachem Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shamim Adil Michal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shamim Adil Michal
Shamim Adil Michal currently holds 1 directorship: Supha Pharmachem Limited (Director, since 22 Jan 2025, revenue ₹233 Cr (FY 2025)).
Shamim Adil Michal was first appointed on 22 Jan 2025 as Director at Supha Pharmachem Limited.
The current boards of Shamim Adil Michal's companies include Adarsh Deepak Munjal (Supha Pharmachem Limited), Ashish Dinanath Parkar (Supha Pharmachem Limited), Bikram Kumar Mund (Supha Pharmachem Limited), Rambhajan Vishwakarma (Supha Pharmachem Limited), Vignesh Laxman Gawde (Supha Pharmachem Limited), Vijay Pal Singh Gulya (Supha Pharmachem Limited).